Cargando…
Use of a multi-gene pharmacogenetic panel reduces adverse drug effects
Swen et al.(1) examine the utility of multi-gene pharmacogenetic testing in a large multi-national cohort. They show fewer adverse drug reactions among patients receiving testing and prescribing recommendations based on genotype results compared with those receiving usual care.
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213803/ https://www.ncbi.nlm.nih.gov/pubmed/37084734 http://dx.doi.org/10.1016/j.xcrm.2023.101021 |